139 related articles for article (PubMed ID: 34948179)
1.
Ragab N; Bauer J; Botermann DS; Uhmann A; Hahn H
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948179
[TBL] [Abstract][Full Text] [Related]
2. Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms.
Bauer J; Cuvelier N; Ragab N; Simon-Keller K; Nitzki F; Geyer N; Botermann DS; Elmer DP; Rosenberger A; Rando TA; Biressi S; Fagin JA; Saur D; Dullin C; Schildhaus HU; Schulz-Schaeffer W; Aberger F; Uhmann A; Hahn H
Oncogene; 2021 Aug; 40(31):4955-4966. PubMed ID: 34172934
[TBL] [Abstract][Full Text] [Related]
3. Uncommitted precursor cells might contribute to increased incidence of embryonal rhabdomyosarcoma in heterozygous Patched1-mutant mice.
Nitzki F; Zibat A; Frommhold A; Schneider A; Schulz-Schaeffer W; Braun T; Hahn H
Oncogene; 2011 Oct; 30(43):4428-36. PubMed ID: 21602886
[TBL] [Abstract][Full Text] [Related]
4. Characterization of genetic lesions in rhabdomyosarcoma using a high-density single nucleotide polymorphism array.
Nishimura R; Takita J; Sato-Otsubo A; Kato M; Koh K; Hanada R; Tanaka Y; Kato K; Maeda D; Fukayama M; Sanada M; Hayashi Y; Ogawa S
Cancer Sci; 2013 Jul; 104(7):856-64. PubMed ID: 23578105
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and survival correlates of embryonal rhabdomyosarcoma driven by RAS/RAF mutations.
Agaram NP; Huang SC; Tap WD; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2022 Mar; 61(3):131-137. PubMed ID: 34755412
[TBL] [Abstract][Full Text] [Related]
6. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
Robbins KM; Stabley DL; Holbrook J; Sahraoui R; Sadreameli A; Conard K; Baker L; Gripp KW; Sol-Church K
Am J Med Genet A; 2016 Dec; 170(12):3197-3206. PubMed ID: 27589201
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
8. Silencing of SPRY1 triggers complete regression of rhabdomyosarcoma tumors carrying a mutated RAS gene.
Schaaf G; Hamdi M; Zwijnenburg D; Lakeman A; Geerts D; Versteeg R; Kool M
Cancer Res; 2010 Jan; 70(2):762-71. PubMed ID: 20068162
[TBL] [Abstract][Full Text] [Related]
9. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.
Huang SC; Alaggio R; Sung YS; Chen CL; Zhang L; Kao YC; Agaram NP; Wexler LH; Antonescu CR
Am J Surg Pathol; 2016 Jul; 40(7):876-85. PubMed ID: 26872011
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway.
Li Z; Zhang Y; Ramanujan K; Ma Y; Kirsch DG; Glass DJ
Cancer Res; 2013 May; 73(10):3041-50. PubMed ID: 23536553
[TBL] [Abstract][Full Text] [Related]
11. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
[TBL] [Abstract][Full Text] [Related]
12. MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis.
Huang HJ; Liu J; Hua H; Li SE; Zhao J; Yue S; Yu TT; Jin YC; Cheng SY
Oncotarget; 2014 Apr; 5(8):2161-75. PubMed ID: 24811402
[TBL] [Abstract][Full Text] [Related]
13. Myc oncogene expression and nude mouse tumorigenicity and metastasis formation are higher in alveolar than embryonal rhabdomyosarcoma cell lines.
Kouraklis G; Triche TJ; Wesley R; Tsokos M
Pediatr Res; 1999 Apr; 45(4 Pt 1):552-8. PubMed ID: 10203148
[TBL] [Abstract][Full Text] [Related]
14. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
[TBL] [Abstract][Full Text] [Related]
15. Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.
Pressey JG; Anderson JR; Crossman DK; Lynch JC; Barr FG
Pediatr Blood Cancer; 2011 Dec; 57(6):930-8. PubMed ID: 21618411
[TBL] [Abstract][Full Text] [Related]
16. NRAS associated RASopathy and embryonal rhabdomyosarcoma.
Garren B; Stephan M; Hogue JS
Am J Med Genet A; 2020 Jan; 182(1):195-200. PubMed ID: 31697451
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.
Nitzki F; Cuvelier N; Dräger J; Schneider A; Braun T; Hahn H
Oncogene; 2016 Jun; 35(22):2923-31. PubMed ID: 26387541
[TBL] [Abstract][Full Text] [Related]
18. Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth.
Ecke I; Rosenberger A; Obenauer S; Dullin C; Aberger F; Kimmina S; Schweyer S; Hahn H
Mol Carcinog; 2008 May; 47(5):361-72. PubMed ID: 17963245
[TBL] [Abstract][Full Text] [Related]
19. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
[TBL] [Abstract][Full Text] [Related]
20. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma.
Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM
PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
